X-153541364-G-A
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_001001344.3(ATP2B3):c.214G>A(p.Ala72Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000438 in 1,210,608 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 172 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. A72A) has been classified as Benign.
Frequency
Consequence
NM_001001344.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ATP2B3 | NM_001001344.3 | c.214G>A | p.Ala72Thr | missense_variant | 4/22 | ENST00000263519.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ATP2B3 | ENST00000263519.5 | c.214G>A | p.Ala72Thr | missense_variant | 4/22 | 1 | NM_001001344.3 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.000506 AC: 57AN: 112573Hom.: 0 Cov.: 24 AF XY: 0.000634 AC XY: 22AN XY: 34723
GnomAD3 exomes AF: 0.000404 AC: 74AN: 183039Hom.: 0 AF XY: 0.000429 AC XY: 29AN XY: 67657
GnomAD4 exome AF: 0.000432 AC: 474AN: 1097984Hom.: 0 Cov.: 32 AF XY: 0.000415 AC XY: 151AN XY: 363474
GnomAD4 genome ? AF: 0.000497 AC: 56AN: 112624Hom.: 0 Cov.: 24 AF XY: 0.000604 AC XY: 21AN XY: 34784
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jan 01, 2018 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Invitae | Dec 29, 2022 | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 16, 2021 | The c.214G>A (p.A72T) alteration is located in exon 2 (coding exon 2) of the ATP2B3 gene. This alteration results from a G to A substitution at nucleotide position 214, causing the alanine (A) at amino acid position 72 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at